The DOI matches its Crossref record; 76 of the 80 references it cites were found in a registry or an index.
Erectile Dysfunction: An Umbrella Review of Meta-Analyses of Risk-Factors, Treatment, and Prevalence Outcomes
Abstract
INTRODUCTION: Erectile dysfunction (ED) is a major health care problem that has implications for quality of life. AIM: This umbrella review sought to synthesize all meta-analytic research on risk factors, treatment, and prevalence of ED. METHODS: 8 electronic databases were searched for relevant meta-analyses in June 2018. The evidence was graded with 2 measures that use quantitative criteria to establish the quality of report writing and confidence in the effect size reported. MAIN OUTCOME MEASURES: Lifestyle factors, genetic markers, medical conditions, treatments. RESULTS: In total, 98 meta-analyses were identified that included 421 meta-analytic effects, 4,188 primary-effects, and 3,971,122 participants. Pooled estimates showed that an unhealthy lifestyle, genetic markers, and medical conditions were associated with an increased risk of ED. Testosterone therapy and phosphodiesterase type 5 inhibitors showed the greatest treatment efficacy, with mild adverse events observed across treatments. Psychological and behavior change interventions produced effect sizes that were comparable to medication but had greater imprecision in effect sizes. There was little evidence that combined treatments were more efficacious than single treatments. Meta-analyses of prevalence estimates showed consistent age trends but were limited to particular regions or clinical samples, meaning that global estimates of ED are difficult to determine. CLINICAL IMPLICATIONS: The umbrella review synthesized findings for many treatment options that might aid evidence-based clinical decision-making. Based on prevalence estimates, we recommend that primary care physicians take a proactive approach and enquire about erectile problems in all men over age 40 displaying any health-related issue (eg, overweight, cigarette smoking). STRENGTHS & LIMITATIONS: Strengths include the calculation and comparison of summary estimates across multiple meta-analyses. Limitations include heterogeneity in research quality across research themes limiting effect size comparisons. CONCLUSION: The review provides summary estimates for 37 risk factors and 28 treatments. Meta-analyses of risk factors often did not control for important confounders, and meta-analyses of randomized trials were not exclusive to double-blinded trials, active placebo controls, or tests of long-term effects. We recommend further meta-analyses that eliminate lower quality studies and further primary research on behavioral and combined treatments. Allen MS, Walter EE. Erectile Dysfunction: An Umbrella Review of Meta-Analyses of Risk-Factors, Treatment, and Prevalence Outcomes. J Sex Med 2019;16:531-541.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Medical treatments, especially pharmacotherapy, are often viewed as more effective and cost-efficient than psychological treatments because the latter raise uncertainty about treatment duration and outcome.49,87,104,105”
From A Psychosocial Approach to Erectile Dysfunction: Position Statements from the European Society of Sexual Medicine (ESSM) (2021) · cites this paper as [104]
Citations
Cites
Measuring inconsistency in meta-analyses
Higgins, J. P. T., Thompson, S. G., Deeks, J. J., & Altman, D. G. (2003) · BMJ · doi:10.1136/bmj.327.7414.557 · Cited by 63,139
Bias in meta-analysis detected by a simple, graphical test
Egger, M., Smith, G. D., Schneider, M., & Minder, C. (1997) · BMJ · doi:10.1136/bmj.315.7109.629 · Cited by 56,722
Operating characteristics of a rank correlation test for publication bias
Begg, C. B., & Mazumdar, M. (1994) · Biometrics · doi:10.2307/2533446 · Cited by 16,955
Shea, B. J., Reeves, B. C., Wells, G., Thuku, M., Hamel, C., Moran, J., Moher, D., Tugwell, P., Welch, V., Kristjansson, E., et al. (2017) · BMJ · doi:10.1136/bmj.j4008 · Cited by 10,636
GRADE guidelines: 3. Rating the quality of evidence
Balshem, H., Helfand, M., Schünemann, H. J., Oxman, A. D., Kunz, R., Brozek, J., Vist, G. E., Falck-Ytter, Y., Meerpohl, J., & Norris, S. (2011) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2010.07.015 · Cited by 8,285
Sterne, J. A. C., Sutton, A. J., Ioannidis, J. P. A., Terrin, N., Jones, D. R., Lau, J., Carpenter, J., Rucker, G., Harbord, R. M., Schmid, C. H., et al. (2011) · BMJ · doi:10.1136/bmj.d4002 · Cited by 7,709
A Nonparametric “Trim and Fill” Method of Accounting for Publication Bias in Meta-Analysis
Duval, S., & Tweedie, R. (2000) · Journal of the American Statistical Association · doi:10.1080/01621459.2000.10473905 · Cited by 2,955
Ekelund, U., Steene-Johannessen, J., Brown, W. J., Fagerland, M. W., Owen, N., Powell, K. E., Bauman, A., & Lee, I.-M. (2016) · The Lancet · doi:10.1016/s0140-6736(16)30370-1 · Cited by 2,648
Aromataris, E., Fernandez, R., Godfrey, C. M., Holly, C., Khalil, H., & Tungpunkom, P. (2015) · International Journal of Evidence-Based Healthcare · doi:10.1097/xeb.0000000000000055 · Cited by 2,587
Shea, B. J., Hamel, C., Wells, G. A., Bouter, L. M., Kristjansson, E., Grimshaw, J., Henry, D. A., & Boers, M. (2009) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2008.10.009 · Cited by 1,755
Flagged first, then by citations
4 of the 80 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 101–116 of 116
Prevalence of Pelvic Health Conditions and Associated Factors in a Male Population
Woodard, C., Krakowsky, M., Widawsky, J., & Wolkenfeld, T. (2025) · Journal of Women s & Pelvic Health Physical Therapy · doi:10.1097/jwh.0000000000000321
Ismail, S. B., Zainon, W. M. N. W., Lotopi, M. A. A., & Nazri, A. (2025) · Malaysian Family Physician · doi:10.51866/cr.764
Abdellatif, A. E., Abdelbary, A. M., Ragheb, A. M., Moussa, A. S., Naguib, M., Elmarakbi, A. A., & Elbatanouny, A. M. (2025) · Arab Journal of Urology · doi:10.1080/20905998.2025.2526978
Patient-Reported Barriers to Sex Therapy for Men Referred by Their Urologist: A Pilot Study
Dumbrava, M. G., Jefferson, F. A., Sischka, M. F., Vencill, J. A., Ziegelmann, M. J., Britton, C. J., Findlay, B. L., Helo, S., Köhler, T., & Collins, C. S. (2025) · Journal of Sex & Marital Therapy · doi:10.1080/0092623x.2025.2551838
Su, L., Zhang, S., Cheng, H.-Y., Zhang, Q., Zhou, Z., Wu, J., & Jiao, Y. (2025) · Food Science & Nutrition · doi:10.1002/fsn3.71062
Haddad, A., Alzarooni, A. I. M. A., Kassem, H., El‐Khoury, J., Hussein, S., Hassan, T., Vignesh, S. O., Siddiqui, U., & Zubaidi, O. (2025) · Journal of Multidisciplinary Healthcare · doi:10.2147/jmdh.s554974
Shao, X., Pei, W., Li, Y., Tan, D., Li, J., & Wang, D. (2025) · Environmental Science & Technology · doi:10.1021/acs.est.5c10372
Rajasekhar, A., Un-Nabi, S. S., Kaliyamoorthy, S., Anusha, D., & Nagalakshmi, S. (2026) · Journal of Pharmacy and Pharmacology · doi:10.1093/jpp/rgag013
Addressing Sexual Health in Primary Care
Bergs, K., Guck, A., & Thompson, S. K. (2026) · Primary Care Clinics in Office Practice · doi:10.1016/j.pop.2026.01.012
Sarcopenia-related traits and erectile dysfunction: a bi-directional Mendelian randomization study
Jianxin, X., Wu, W.-S., Dengpan, F., Yiwei, W., & Fangmin, C. (2026) · Sexual Medicine · doi:10.1093/sexmed/qfag010
Delbarba, A., Ugoccioni, M., Gatta, E., Tiecco, G., Quirós-Roldán, E., Graziani, A., Pirola, I., Ferlin, A., & Cappelli, C. (2026) · Journal of Endocrinological Investigation · doi:10.1007/s40618-026-02889-1
Determination of Sexual Problems and Affecting Factors in Male Type 2 Diabetes Patients
Asal, M., & Akkuş, Y. (2026) · Sexuality and Disability · doi:10.1007/s11195-026-09942-0
Помешкин, Е. В., Кызласов, П. С., Volokitin, E. V., & Neymark, B. A. (2026) · Urology reports (St - Petersburg) · doi:10.17816/uroved696831
Savira, M., Birowo, P., Rasyid, N., Chung, E., & Atmoko, W. (2026) · Asian Journal of Andrology · doi:10.4103/aja202588
Broul, M., Dubský, M., Hujová, A., & Liegertová, M. (2026) · Andrology · doi:10.1111/andr.70366 · Cited by 1
Management of erectile dysfunction in phosphodiesterase type 5 inhibitor nonresponders
Barros, R., Crelier, G. M., & Favorito, L. A. (2026) · Current Opinion in Urology · doi:10.1097/mou.0000000000001438
Metadata
- Authors
- Allen, M. S., & Walter, E. E.
- Affiliations
- University of Wollongong (AU)
- Corresponding author
- Allen, Mark S.
- Venue
- The Journal of Sexual Medicine
- Publisher
- Oxford University Press (OUP)
- Published
- 2019-03-01
- Volume
- 16
- Issue
- 4
- Pages
- 531-541
- ISSN
- 1743-6095 (ISSN-L)
- 1743-6109
- OpenAlex
- W2920406111
- Cited by
- 116
- References
- 80
- Citations by year
- 2026: 12 · 2025: 22 · 2024: 14 · 2023: 16 · 2022: 15 · 2021: 16 · 2020: 16 · 2019: 5
- FWCI
- 2.20
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- Locations
- The Journal of Sexual Medicine (publishedVersion)
- PubMed (publishedVersion)
- Research Online (University of Wollongong) (submittedVersion)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Sexual function and dysfunction studies
- Health Sciences › Medicine › Urology › Urological Disorders and Treatments
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
- Keywords
- erectile dysfunction, risk factors, erectile dysfunction treatment, testosterone replacement therapy, phosphodiesterase-5 inhibitors, lifestyle factors, genetic markers, health conditions, psychological intervention, behavioral interventions, combination therapy, adverse events, quality of evidence, primary care screening
- MeSH terms
- Combined Modality Therapy, Humans, Erectile Dysfunction, Life Style, Male, Quality of Life, Risk Factors, Prevalence, Treatment Outcome, Phosphodiesterase 5 Inhibitors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
